compound semaglutide ending glp 1 Switching from a compounded to a brand-name GLP-1? Here's how to do it in 5 steps Compound versions of GLP-1 drugs – The Semaglutide Shortage Is Ending:

We are now seeing many more research studies for other indications and treatment with these drugs

ERJ Open Res 2022;8

While its not known whether microdosing GLP-1s leads to a longer life, there is evidence that standard doses of the drugs can help lower inflammation throughout the body, according to the Post

Source: Pocket Manual of Therapy (Bartoccioni et al.) / FDA News To view or add a comment, sign in 186 followers

Preclinical Data Point to a Meaningful Competitive Edge Preclinical data from SureNano Science suggest that GEP-44 may offer substantive differentiation relative to earlier-generation GLP therapies